SPHK1/S1PR1/PPAR-α axis restores TJs between uroepithelium providing new ideas for IC/BPS treatment
Life Science Alliance · 2025
DOI: 10.26508/lsa.202402957 ↗Kurz gefasst
Fachartikel in der Zeitschrift Life Science Alliance, 2025. Verfasst von Junjie Zhang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, The Second Affiliated Hospital of Nanjing Medical University, Nanjing, China. Hauptthemen laut MEDLINE: Sphingosine-1-Phosphate Receptors, Phosphotransferases (Alcohol Group Acceptor), PPAR alpha, Sphingosine. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: MOST | National Natural Science Foundation of China.
Abstract (Originalsprache)
Interstitial cystitis/bladder pain syndrome (IC/BPS) represents a chronic, aseptic inflammatory bladder condition with an unclear etiology and few therapeutic options. A composite barrier structure composed of the uroepithelium and glycosaminoglycan layer forms on the bladder’s inner surface to block urine and other harmful substances. Dysfunction of this barrier may initiate the pathogenesis of IC/BPS. Sphingosine-1-phosphate (S1P) plays a crucial role in forming tight junctions. Perfusion of S1P into the bladder restored uroepithelial tight junctions in mice with cyclophosphamide-induced acute cystitis and ameliorated symptoms of the lower urinary tract. Mice lacking sphingosine kinase 1 (SHPK1) exhibited more severe bladder injuries and dysfunction. Concurrent in vitro experiments elucidated S1P’s protective effects and its role as a primary messenger through SPHK1 and S1P receptor 1 (S1PR1) knockdown. This study identifies a novel mechanism whereby S1P binding to S1PR1 activates the PPAR-α pathway, thereby enhancing cholesterol transport and restoring tight junctions between uroepithelial cells. These findings elucidate the regulatory role of S1P in the bladder epithelial barrier and highlight a promising therapeutic target for IC/BPS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Urology, The Second Affiliated Hospital of Nanjing Medical University, Nanjing, China.
- Department of Urology, The Second Clinical Medical College of Nanjing Medical University, Nanjing, China.
- Respiratory Department, Children's Hospital of Nanjing Medical University, Nanjing, China.
- Nanjing Medical University, Nanjing, China.
- Department of Urology, The Second Affiliated Hospital of Nanjing Medical University, Nanjing, China Weizq11@163.com.
- Department of Urology, The Second Affiliated Hospital of Nanjing Medical University, Nanjing, China baixinshen@njmu.edu.cn.
ORCID-Profile: Junjie Zhang, Zhongqing Wei, Baixin Shen
Förderung
- MOST | National Natural Science Foundation of China
Zitieren
APA
Zhang, J., Ge, Q., Du, T., Kuang, Y., Fan, Z., Jia, X., Gu, W., Chen, Z., Wei, Z., & Shen, B. (2025). SPHK1/S1PR1/PPAR-α axis restores TJs between uroepithelium providing new ideas for IC/BPS treatment. Life Science Alliance. https://doi.org/10.26508/lsa.202402957
Vancouver
Zhang J, Ge Q, Du T, Kuang Y, Fan Z, Jia X, et al. SPHK1/S1PR1/PPAR-α axis restores TJs between uroepithelium providing new ideas for IC/BPS treatment. Life Science Alliance. 2025. doi:10.26508/lsa.202402957
BibTeX
@article{Zhang2025,
author = {Zhang, Junjie and Ge, Qingyu and Du, Tianpeng and Kuang, Yuhao and Fan, Zongyao and Jia, Xinyi and Gu, Wenjin and Chen, Zhengsen and Wei, Zhongqing and Shen, Baixin},
title = {SPHK1/S1PR1/PPAR-α axis restores TJs between uroepithelium providing new ideas for IC/BPS treatment},
journal = {Life Science Alliance},
year = {2025},
doi = {10.26508/lsa.202402957}
}
EUVIMED